title: Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point?
authors.forename: Frans A
authors.initials: FA
authors.lastname: van Nieuwenhoven
authors.forename: Louise J N
authors.initials: LJ
authors.lastname: Jensen
authors.forename: Allan
authors.initials: A
authors.lastname: Flyvbjerg
authors.forename: Roel
authors.initials: R
authors.lastname: Goldschmeding
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D055513:Connective Tissue Growth Factor; D003928:Diabetic Nephropathies / Q000097:blood / Q000175:diagnosis*; D018450:Disease Progression; D005260:Female; D006801:Humans; D017874:Immediate-Early Proteins / Q000032:analysis / Q000378:metabolism*; D036341:Intercellular Signaling Peptides and Proteins / Q000032:analysis / Q000378:metabolism*; D008297:Male; D011379:Prognosis; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D016212:Transforming Growth Factor beta / Q000032:analysis / Q000378:metabolism*
chemical_list: D015415:Biomarkers; C526317:CCN2 protein, human; D017874:Immediate-Early Proteins; D036341:Intercellular Signaling Peptides and Proteins; D016212:Transforming Growth Factor beta; D055513:Connective Tissue Growth Factor